Product Information
OFLOXACIN 0.3% EYE DROPS is a generic product labeled by SOLA Pharmaceuticals LLC, priced at $1.2414 per ML under NDC 70512079305. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Apr 12, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
SOLA Pharmaceuticals LLCNDC
70512079305
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217904FDA Approved
4/12/2024
TE Code
AT
On Market Since
4/30/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EYE DROPS has been published 116 times since Jul 17, 2024, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2414 per ML |
|---|---|
| All-time high | $2.0989 (Sep 11, 2024) |
| All-time low | $1.2414 (Sep 23, 2026) |
| 52-week high | $1.6279 |
| 52-week low | $1.2414 |
| Median price | $1.6067 |
| Average price | $1.5556 |
| Largest weekly change | +28.4% (Aug 21, 2024) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SOLA Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ofloxacin Ophthalmic Solution USP, 0.3% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EYE DROPS, manufactured by SOLA Pharmaceuticals LLC, is $1.2414 per ML (NDC 70512079305), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EYE DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EYE DROPS has declined 24.0%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EYE DROPS?
Since Jul 17, 2024, the NADAC for OFLOXACIN 0.3% EYE DROPS has ranged from a low of $1.2414 (Sep 23, 2026) to a high of $2.0989 (Sep 11, 2024), with a median of $1.6067 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EYE DROPS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OFLOXACIN 0.3% EYE DROPS, is $1.1136 per ML — about 10% below OFLOXACIN 0.3% EYE DROPS.
Who manufactures OFLOXACIN 0.3% EYE DROPS?
OFLOXACIN 0.3% EYE DROPS (NDC 70512079305) is labeled by SOLA Pharmaceuticals LLC, and CMS classifies it as a generic product.